VANECK PHARMACEUTICAL ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.8 USD | +0.32% |
|
+2.27% | +6.68% |
Investment objective
VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 733.5 USD | +1.19% | +0.99% | +25.83% | 9.76% | ||
| 146.1 USD | -0.46% | -1.20% | -6.76% | 6.36% | ||
| 131.2 USD | +0.37% | +4.31% | +20.34% | 5.84% | ||
| 159.6 USD | -4.58% | -4.08% | +3.00% | 5.46% | ||
| 240.9 USD | +0.47% | +0.73% | +17.29% | 4.82% | ||
| 543.3 USD | +0.62% | +3.52% | +17.35% | 4.48% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 86.8 | +0.32% | 616,575 |
| 25/04/24 | 86.52 | +0.17% | 347,614 |
| 24/04/24 | 86.37 | -0.63% | 91,320 |
| 23/04/24 | 86.92 | +1.16% | 190,081 |
| 22/04/24 | 85.92 | +0.92% | 48,400 |
Other stock markets
Delayed Quote Nasdaq
Last update April 26, 2024 at 09:00 pm
More quotesETF Ratings
 |
Description
| US92189F6925 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MVIS US Listed Pharmaceutical 25 Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Fund Structure | |
| Replication Method | |
| Replication Model | |
| Date of creation |
19/12/2011
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 27/03/2024 )
| AuM (EUR) | 503 M€ |
|---|---|
| AuM 1M | 475 M€ |
| AuM 3 months | 395 M€ |
| AuM 6 months | 407 M€ |
| AuM 12 months | 338 M€ |
- Stock Market
- ETF
- PPH ETF
